series-b
Stage
2026
Founded
3
Investors
About
Angiodroid develops and markets an automatic CO2 injector for angiographic imaging, utilizing carbon dioxide as a biocompatible alternative to iodine contrast media. This technology enhances patient safety and diagnostic clarity, particularly for individuals with renal impairment or iodine allergies.
Explore Angiodroid's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.